{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:28:18Z","timestamp":1778711298560,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T00:00:00Z","timestamp":1287014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s12325-010-0076-8","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T01:06:24Z","timestamp":1287104784000},"page":"870-878","source":"Crossref","is-referenced-by-count":55,"title":["Hyaluronic acid improves \u201cpleasantness\u201d and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis"],"prefix":"10.1007","volume":"27","author":[{"given":"Paolo","family":"Buonpensiero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"De Gregorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Sepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Di Pasqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasqualina","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Siano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Terlizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Raia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,14]]},"reference":[{"key":"76_CR1","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","volume":"373","author":"B.P. O\u2019sullivan","year":"2009","unstructured":"O\u2019sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373:1891\u20131904.","journal-title":"Lancet"},{"key":"76_CR2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.1375392","volume":"256","author":"F.S. Collins","year":"1992","unstructured":"Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science. 1992;256:774\u2013779.","journal-title":"Science"},{"key":"76_CR3","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0092-8674(93)90353-R","volume":"73","author":"M.J. Welsh","year":"1993","unstructured":"Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993;73:1251\u20131254.","journal-title":"Cell"},{"key":"76_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2796.2006.01744.x","volume":"261","author":"R.C. Boucher","year":"2007","unstructured":"Boucher RC. Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med. 2007;261:5\u201316.","journal-title":"J Intern Med."},{"key":"76_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","volume":"354","author":"M.R. Elkins","year":"2006","unstructured":"Elkins MR, Robinson M, Rose BR, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med. 2006;354:229\u2013240.","journal-title":"N Engl J Med."},{"key":"76_CR6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ppul.20603","volume":"42","author":"P. Subbarao","year":"2007","unstructured":"Subbarao P, Balkovec S, Solomon M, Ratjen F. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis. Pediatr Pulmonol. 2007;42:471\u2013476.","journal-title":"Pediatr Pulmonol."},{"key":"76_CR7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","volume":"176","author":"P.A. Flume","year":"2007","unstructured":"Flume PA, O\u2019sullivan BP, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007;176:957\u2013969.","journal-title":"Am J Respir Crit Care Med."},{"key":"76_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","volume":"354","author":"S.H. Donaldson","year":"2006","unstructured":"Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med. 2006;354:241\u2013250.","journal-title":"N Engl J Med."},{"key":"76_CR9","first-page":"CD001506","volume":"15","author":"P. Wark","year":"2009","unstructured":"Wark P, McDonald VM. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev. 2009;15:CD001506.","journal-title":"Cochrane Database Syst Rev."},{"key":"76_CR10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.mcp.0000245714.89632.b2","volume":"12","author":"M.R. Elkins","year":"2006","unstructured":"Elkins MR, Bye PT. Inhaled hypertonic saline as a therapy for cystic fibrosis. Curr Opin Pulm Med. 2006;12:445\u2013452.","journal-title":"Curr Opin Pulm Med."},{"key":"76_CR11","first-page":"1","volume-title":"Glycosaminoglycans and proteoglycans in physiological and pathological processes of body systems","author":"R.C. Rosenberg","year":"1982","unstructured":"Rosenberg RC, Varma R. An overview of proteoglycans in physiology and pathology. In: Varma RS, Varma R, eds. Glycosaminoglycans and proteoglycans in physiological and pathological processes of body systems. Basel: Karger; 1982;1\u20134."},{"key":"76_CR12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1094-5539(03)00089-0","volume":"16","author":"M. Scuri","year":"2003","unstructured":"Scuri M, Abraham WM. Hyaluronan blocks human neutrophil elastase (HNE)-induced airway responses in sheep. Pulm Pharmacol Ther. 2003;16:335\u2013340.","journal-title":"Pulm Pharmacol Ther."},{"key":"76_CR13","first-page":"703","volume-title":"Chemistry and molecular biology of the intercellular matrix","author":"T.C. Laurent","year":"1970","unstructured":"Laurent TC. Structure of hyaluronic acid. In: Balazs EA, ed. Chemistry and molecular biology of the intercellular matrix. London: Academic Press; 1970;703\u2013732."},{"key":"76_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2796.1997.00170.x","volume":"242","author":"J.R.E. Fraser","year":"1997","unstructured":"Fraser JRE, Laurent TC, Laurent UBG. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242:27\u201333.","journal-title":"J Intern Med."},{"key":"76_CR15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/bj2500435","volume":"250","author":"M.W.A. Holmes","year":"1988","unstructured":"Holmes MWA, Bayliss MT, Muir H. Hyaluronic acid in human articular cartilage. Biochem J. 1988;250:435\u2013441.","journal-title":"Biochem J."},{"key":"76_CR16","first-page":"L379","volume":"257","author":"O. Nettelbladt","year":"1989","unstructured":"Nettelbladt O, Tengblad A, Hallgren R. Lung accumulation of hyaluronan parallels pulmonary edema in experimental alveolitis. Am J Physiol. 1989;257:L379\u2013L384.","journal-title":"Am J Physiol."},{"key":"76_CR17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0304-4165(82)90266-5","volume":"716","author":"K. Schmid","year":"1982","unstructured":"Schmid K, Grundboeck-Jusco J, Kimura A, et al. The distribution of the glycosamino- glycans in the anatomic components of the lung and the changes in concentration of these macromolecules during development and aging. Biochim Biophys Acta. 1982;716:178\u2013187.","journal-title":"Biochim Biophys Acta"},{"key":"76_CR18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1164\/rccm.200205-449PP","volume":"167","author":"G.M. Turino","year":"2003","unstructured":"Turino GM, Cantor O. Hyaluronan in respiratory injury and repair. Am J Respir Crit Care Med. 2003;167:1169\u20131175.","journal-title":"Am J Respir Crit Care Med."},{"key":"76_CR19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1164\/ajrccm.153.1.8542136","volume":"153","author":"P. Venge","year":"1996","unstructured":"Venge P, Pedersen B, Hakansson L, Hallgren R, Lindblad G, Dahl R. Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis. Am J Respir Crit Care Med. 1996;153:312\u2013316.","journal-title":"Am J Respir Crit Care Med."},{"key":"76_CR20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pupt.2005.03.002","volume":"19","author":"G. Petrigni","year":"2006","unstructured":"Petrigni G, Allegra L. Aerosolised hyaluronic acid prevents exercise-induced bronchoconstrinction, suggesting novel hypotheses on the correction of matrix defects in asthma. Pul Pharmacol Ther. 2006;19:166\u2013171.","journal-title":"Pul Pharmacol Ther."},{"key":"76_CR21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pupt.2005.04.011","volume":"19","author":"L.I. Kunz","year":"2006","unstructured":"Kunz LI, van Rensen EL, Sterk PJ. Inhaled hyaluronic acid against exercise-induced bronchoconstriction in asthma. Pulm Pharmacol Ther. 2006;19:286\u2013291.","journal-title":"Pulm Pharmacol Ther."},{"key":"76_CR22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-3476(97)70064-7","volume":"131","author":"P.M. McIlwaine","year":"1997","unstructured":"McIlwaine PM, Wong LT, Peacock D, Davidson AG. Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis. J Pediatr. 1997;131:570\u2013574.","journal-title":"J Pediatr."},{"key":"76_CR23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1037\/0021-9010.83.2.324","volume":"83","author":"J.T. Maurer","year":"1998","unstructured":"Maurer JT, Pierce HR. A comparison of Likert scale and traditional measures of self-efficacy. J Appl Psychol. 1998;83:324\u2013349.","journal-title":"J Appl Psychol."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-010-0076-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-010-0076-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-010-0076-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:55:58Z","timestamp":1559462158000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-010-0076-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,14]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1007\/s12325-010-0076-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,14]]}}}